The Alliance for Regenerative Medicine, a Washington-based lobbying group, will hold its general membership meeting at the World Stem Cell Summit Oct. 4-6 in Detroit. Members of the alliance include large firms like Johnson & Johnson and Corning, as well as smaller venture-backed firms in the burgeoning field. Bernard Siegel, founder and co-chair of the summit and executive director of the Genetics Policy Institute, said the events panel discussions “are designed to address the needs of the life science investor community and executives from biotechnology, pharmaceutical and other regenerative medicine companies.”
Recent Posts
- ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer
- World-first stem-cell treatment restores vision in people
- Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease
- Markers in iPSC quality control—a new approach to enhance standardization
- Nasal Spray Made From Stem Cells Could Treat Alzheimer’s Disease
- New Stem Cell Data From Space